ProMetic Life Sciences Inc. (PLI:TSX) Annual Reports & Investor Relations Material

Overview

ProMetic Life Sciences Inc. is a biopharmaceutical company that is primarily involved in researching, developing, manufacturing, and marketing drug therapeutics and protein technologies. The company's In-House Therapeutics segment specializes in developing drug candidates for the treatment of hematological and nephrological disorders, as well as cancer. ProMetic's primary focus is on developing drug therapeutics to treat blood-related disorders.

Annual Reports

Frequently Asked Questions

What is ProMetic Life Sciences Inc.'s ticker?

ProMetic Life Sciences Inc.'s ticker is PLI

What exchange is ProMetic Life Sciences Inc. traded on?

The company's shares trade on the TSX stock exchange

Where are ProMetic Life Sciences Inc.'s headquarters?

They are based in Laval, Quebec

How many employees does ProMetic Life Sciences Inc. have?

There are 51-200 employees working at ProMetic Life Sciences Inc.

What is ProMetic Life Sciences Inc.'s website?

It is http://www.prometic.com/

What type of sector is ProMetic Life Sciences Inc.?

ProMetic Life Sciences Inc. is in the Healthcare sector

What type of industry is ProMetic Life Sciences Inc.?

ProMetic Life Sciences Inc. is in the Biotechnology industry

Who are ProMetic Life Sciences Inc.'s peers and competitors?

The following five companies are ProMetic Life Sciences Inc.'s industry peers:

- Homology Medicines

- Intercept Pharmaceuticals

- Mesoblast

- Albireo Pharma

- Immutep Limited